Kirkland & Ellis announced on May 6 that it advised Knox Lane, a growth-oriented investment firm, in its agreement to acquire Cross Country Healthcare, Inc. The transaction involves the purchase of all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash deal valued at $437 million. The closing is expected in the third quarter of 2026 and remains subject to customary closing conditions.
The agreement marks a significant development for both companies, with Cross Country Healthcare described as a leading technology-driven healthcare workforce solutions provider. This acquisition represents a major investment by Knox Lane into the healthcare sector.
The Kirkland & Ellis team working on this transaction included corporate lawyers Hamed Meshki, Dan Guerin, James Brownstein, Daniel Wolf, Rachael Coffey, Lilybelle Abraham, Joseph Grib, Elizabeth Amanieh and Jennifer Leserman; tax lawyers Anne Kim and David Gilbert; executive compensation lawyers Scott Price, Daniel Rios and Cassie Ashley; employment and labor lawyers Kevin Miller, Erin Davey and Shyion Byfield; healthcare lawyers Dennis Williams and Kelly Kluka; as well as antitrust and competition lawyers Andrea Murino, Psalm Cheung and Joe Krisko.
No further details about operational changes or future plans have been released at this time.
